(Q48131098)

8 February 2018

title

Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens (English)

1 reference

8 February 2018

1 reference

2

1 reference

8 February 2018

Marco Racchi

4

1 reference

8 February 2018

Massimo Grilli

6

1 reference

8 February 2018

author name string

Stefania Preda

1

1 reference

8 February 2018

Cristina Lanni

3

1 reference

8 February 2018

Elisa Mura

5

1 reference

8 February 2018

Mario Marchi

7

1 reference

8 February 2018

language of work or name

English

0 references

publication date

20 June 2007

1 reference

8 February 2018

published in

Neuropsychopharmacology

1 reference

8 February 2018

volume

33

1 reference

8 February 2018

issue

5

1 reference

8 February 2018

page(s)

1062-1070

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301485

exact match

0 references

cites work

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Executive function deficits in early Alzheimer's disease and their relations with episodic memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Evidence for a relationship between B-50 (GAP-43) and [3H]noradrenaline release in rat brain synaptosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Working memory and learning in early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

The aging brain: morphomolecular senescence of cortical circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

APP processing and synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Behavioural and neurochemical effects of cholinergic and dopaminergic agonists administered into the accumbal core and shell in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Beta-amyloid1-40 inhibits electrically stimulated release of [3H]norepinephrine and enhances the internal calcium response to low potassium in rat cortex: prevention with a free radical scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Allosteric modulation of the presynaptic Ca2+ sensor for vesicle fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Dopamine and the regulation of cognition and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Relational integration and executive function in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Impaired Modulation of GABAergic Transmission by Muscarinic Receptors in a Mouse Transgenic Model of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein--infused rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

7 January 2021

Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid beta protein (A beta) only in the form of A beta 42(43)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

7 January 2021

Presynaptic muscarinic receptor activation enhances striatal dopamine release evoked by depolarization but not that induced by non-depolarizing stimuli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

7 January 2021

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

7 January 2021

Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

7 January 2021

Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

7 January 2021

Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301485

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301485

1 reference

8 February 2018

release_dpzhycyndjdbvalt6moqtezlw4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dpzhycyndjdbvalt6moqtezlw4

24 November 2022

mapped directly with Wikidata item

1 reference

8 February 2018